{
    "2021-03-23": [
        [
            {
                "time": "2021-03-23",
                "original_text": "A股收盘综述：上证指数跌0.93%守住3400，茅台、五粮液、金龙鱼等尾盘拉升",
                "features": {
                    "keywords": [
                        "上证指数",
                        "茅台",
                        "五粮液",
                        "金龙鱼",
                        "尾盘拉升"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "金融",
                        "消费"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-03-23",
                "original_text": "迈瑞医疗、金龙鱼、智飞生物、爱尔眼科齐涨，创业板指逐步企稳",
                "features": {
                    "keywords": [
                        "迈瑞医疗",
                        "金龙鱼",
                        "智飞生物",
                        "爱尔眼科",
                        "创业板指"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "消费",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-23",
                "original_text": "医药行业周报：新修订《医疗器械监督管理条例》发布 创新纳入发展重点",
                "features": {
                    "keywords": [
                        "医疗器械",
                        "监督管理条例",
                        "创新",
                        "发展重点"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-03-23",
                "original_text": "医药生物行业周观点：择机布局调整到位的个股",
                "features": {
                    "keywords": [
                        "医药生物",
                        "择机布局",
                        "调整到位"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-23",
                "original_text": "智飞生物：安徽省应急采购公司新冠疫苗，新冠疫苗放量在即！【东吴医药朱国广团队】",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "新冠疫苗",
                        "应急采购",
                        "放量在即"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-23",
                "original_text": "医药生物行业周报：关注新冠疫苗接种提速带来的业绩弹性",
                "features": {
                    "keywords": [
                        "医药生物",
                        "新冠疫苗",
                        "接种提速",
                        "业绩弹性"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-23",
                "original_text": "东吴证券：智飞生物(300122.SZ)新冠疫苗放量在即，维持“买入”评级",
                "features": {
                    "keywords": [
                        "东吴证券",
                        "智飞生物",
                        "新冠疫苗",
                        "买入评级"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-23",
                "original_text": "医药与健康护理行业周报：估值风险有效控制 关注业绩高增长公司",
                "features": {
                    "keywords": [
                        "医药",
                        "健康护理",
                        "估值风险",
                        "业绩高增长"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "健康护理"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-23",
                "original_text": "医药生物行业跨市场周报：Q1业绩期临近 小阳春行情可期",
                "features": {
                    "keywords": [
                        "医药生物",
                        "Q1业绩期",
                        "小阳春行情"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-23",
                "original_text": "东吴证券给予智飞生物买入评级，安徽省应急采购公司新冠疫苗，新冠疫苗放量在即",
                "features": {
                    "keywords": [
                        "东吴证券",
                        "智飞生物",
                        "新冠疫苗",
                        "应急采购",
                        "放量在即"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-23",
                "original_text": "基民不能承受之重，个别基金经理押注板块赌明天",
                "features": {
                    "keywords": [
                        "基民",
                        "基金经理",
                        "押注板块",
                        "赌明天"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "基金"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}